GlassScriptPhysician profile
Ashley I Vachon
NPI 1184042582
$1,614.66
in general payments reported to CMS, 2019-2025
16 companies · $583 in 2025
The $583 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $97.80 · 2022: $30.82 · 2023: $448 · 2024: $456 · 2025: $583.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,472 · Education: $14.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,471.87 |
| Education | $14.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $851.79 | 2021-2025 | Rinvoq, Skyrizi |
| Lilly USA, LLC | $138.93 | 2024 | Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $124.43 | 2023 | Entyvio |
| Genzyme Corporation | $96.41 | 2023-2025 | |
| Pfizer INC. | $86.39 | 2021-2025 | |
| Gilead Sciences, INC. | $57.38 | 2024-2025 | |
| Axonics, INC. | $53.69 | 2024 | Axonics |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.72 | 2022-2024 | Xifaxan |
| Celgene Corporation | $39.34 | 2023 | Zeposia |
| Ardelyx, INC. | $25.16 | 2023 | Ibsrela |
| Alnylam Pharmaceuticals INC. | $24.80 | 2021 | |
| Nestle Healthcare Nutrition INC. | $19.56 | 2021 | |
| Celltrion USA INC. | $14.17 | 2024 | Zymfentra |
| Janssen Biotech, INC. | $14.08 | 2023 | Stelara |
| Ferring Pharmaceuticals INC. | $13.73 | 2025 | Rebyota |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Vachon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.